Asclepius MedTech Limited Named Winner of Big Ideas Challenge

Key Takeaways

• £100k grant (~$127k) funds Surgfit rollout
• Wearable sensor replaces in‑hospital risk assessments
• Targets 50% higher missed appointments in minority groups
• Aims to cut surgical complications and readmissions
• Part of UK Shared Prosperity Fund health‑inequality program

Summary

Leeds‑based Asclepius MedTech Limited won the Mayor’s Big Ideas Challenge, receiving £100,000 (≈ $127,000) to scale its Surgfit remote monitoring system. Surgfit uses a disposable wearable sensor to replace hospital visits for pre‑ and post‑operative assessments, aiming to reduce missed risk assessments, complications, and readmissions in West Yorkshire. The award, funded through the UK Shared Prosperity Fund, underscores a growing focus on technology to close health‑inequality gaps.

Pulse Analysis

The Mayor’s Big Ideas Challenge, launched by West Yorkshire Mayor Tracy Brabin, is a targeted effort to harness innovation against entrenched health disparities. In the UK, socioeconomic and ethnic factors contribute to a persistent gap in access to pre‑operative assessments, with one‑third of patients missing critical risk evaluations. By allocating £100,000 (about $127,000) from the UK Shared Prosperity Fund, the program signals a shift toward data‑driven, community‑level solutions that can be replicated in other regions facing similar inequities. The challenge also encourages collaboration between local accelerators, universities, and NHS trusts, creating an ecosystem for rapid prototyping.

Surgfit, Asclepius MedTech’s flagship product, combines a disposable seven‑day wearable sensor with a cloud‑based analytics platform to deliver continuous physiological data to clinicians. The system eliminates the need for frail or disabled patients to travel to hospitals for routine checks, directly addressing the 50 % higher missed‑appointment rate among minority and low‑income groups in West Yorkshire. Early pilots suggest the technology can reduce post‑operative complications and readmissions, translating into millions of pounds saved for the NHS while improving patient satisfaction and safety. Clinicians receive real‑time alerts when vital signs deviate from predefined thresholds, enabling proactive interventions before complications arise.

The infusion of public capital into Surgfit underscores a growing consensus that digital health tools are essential for sustainable NHS reform. If the rollout proves successful, private investors and larger health‑tech firms may follow, accelerating a market for remote surgical monitoring across the UK and Europe. Moreover, the data generated by widespread wearable use could inform population‑level research, guiding policy decisions on resource allocation and preventive care. Asclepius MedTech’s win therefore represents both a local breakthrough and a potential catalyst for systemic change. Long‑term, the aggregated dataset could support AI‑driven predictive models, further personalizing peri‑operative care pathways.